By Evan Chait, licensed Physical Therapist and Acupuncturist
Quick answer (TL;DR) “Regular” stem cells, such as mesenchymal stem cells (MSCs), mostly turn into a limited set of related tissue cells and are thought to help mainly by sending repair signals. MUSE cells are a rare group found inside those same tissues. In laboratory studies they can form cells from all three germ layers, and they appear to home to injury on their own. The tradeoff is that MUSE research is newer and smaller. Neither type is FDA-approved as a standard treatment for the conditions most patients ask about.
If you are comparing stem cell treatment options, you have probably noticed that every clinic seems to offer “stem cells,” yet very few mention MUSE cells. That raises a fair question: what actually separates MUSE cells from regular stem cells, and does the difference matter for a patient?
This guide compares them side by side in plain language. If you are new to the topic, start with our full guide on what MUSE cells are and then come back here for the head-to-head view.
What Do We Mean by “Regular” Stem Cells?
There is no single “regular” stem cell. The phrase usually means one of four groups, and each behaves differently.
1. Tissue-specific (adult) stem cells. These live in tissues such as bone marrow and help maintain them. Blood-forming stem cells are the best-known example. They have a long track record in treating certain blood and immune conditions.
2. Mesenchymal stem cells (MSCs). These come from bone marrow, fat, or umbilical cord tissue. MSCs are the cells most stem cell clinics use today. You can read how they are used on our umbilical cord stem cells page.
3. Embryonic stem cells. These come from early-stage embryos and can become nearly any cell type. They are mainly a research tool, and they raise both ethical debate and safety concerns.
4. Induced pluripotent stem cells (iPSCs). These begin as ordinary adult cells that scientists reprogram with added genes so they behave like embryonic cells. They are powerful in the lab, but controlling their growth is a major hurdle for patient use.
When most patients ask about “regular stem cells,” they mean the MSCs offered in clinics. That is the comparison we focus on below.
The Big Difference: Signaling vs Direct Repair
The cleanest way to understand the gap is to ask how each cell is thought to help.
MSCs are mostly messengers. Current thinking is that MSCs work mainly through paracrine signaling. In other words, they release molecules that calm inflammation and encourage nearby cells to do their own repair work. The MSC itself often does not stay long or become new tissue.
MUSE cells may be builders as well as messengers. In laboratory and animal studies, MUSE cells moved toward injured tissue, settled there, and took on the features of local cells. Tohoku University’s research group describes them as sensing a damage signal called sphingosine-1-phosphate (S1P) and accumulating at the injury. If that behavior holds up in people, it would mean they could both signal and contribute to tissue directly.
Notice the words “may” and “if.” This is a promising mechanism seen in lab and animal work. It is not yet a proven clinical advantage.
Side-by-Side Comparison
| Question | Regular MSCs | MUSE Cells |
|---|---|---|
| What are they? | A broad group of cells from bone marrow, fat, or cord tissue | A rare subgroup found within mesenchymal cell populations |
| How are they identified? | Standard mesenchymal markers | SSEA-3 plus CD105 |
| How common are they? | Abundant and easy to grow | Small share of the total population, needs special isolation |
| Main way they are thought to help | Releasing repair signals | Homing to damage, plus signaling |
| Range of cell types in lab studies | Limited, related tissue types | Broader, including all three germ layers from a single cell |
| Growth behavior | Grow readily | Low proliferation, self-limiting |
| Body of human research | Large, with mixed results by condition | Early and still growing |
| Typical availability at U.S. clinics | Widely offered | Offered by a small number of providers |
The most important detail in this table is the second to last row. MSCs have been studied far longer, and the results are mixed, which is exactly why careful patients should ask for evidence for any specific condition. MUSE cells have less human data, not more.
A Surprising Fact: MUSE Cells Are Already Inside “Regular” Stem Cells
Many people think of MUSE cells and MSCs as two competing products. The research tells a more interesting story.
When Professor Mari Dezawa’s team at Tohoku University first described MUSE cells in 2010, they found them inside ordinary human mesenchymal cell populations, including bone marrow cells and skin fibroblasts. You can read the original findings in the 2010 study on PubMed Central.
So a standard MSC preparation may contain a small number of MUSE cells, but they are diluted among many others. Dedicated isolation methods are designed to concentrate them. This also helps explain the logic behind the idea that MUSE cells could add something that routine MSC preparations do not deliver in meaningful numbers.
Safety: Why the Growth Behavior Matters
Cells that can become many tissue types are powerful, but cells that also divide without limit can form tumors. That is the main safety concern with embryonic stem cells and iPSCs.
The International Society for Stem Cell Research (ISSCR), a respected nonprofit, advises in its patient guide to stem cell treatments that undifferentiated pluripotent stem cells are not safe to inject into patients. It is a useful reminder to take any pluripotent claim seriously.
Here is where MUSE cells fit into that picture, based on published research:
- The 2010 discovery paper described MUSE cells as non-tumorigenic and noted modest proliferation.
- Later work in fat-derived MUSE cells reported low telomerase activity, which fits with cells that do not divide endlessly.
- Published animal studies have not reported tumor formation from transplanted MUSE cells.
This is encouraging, and it is a major reason MUSE cells are drawing attention. But it is not the same as long-term proof in people. A responsible provider will tell you that long-term human safety data are still limited and that every cell-based procedure carries some risk.
Regulation: What FDA Status Means for You
The regulatory picture is similar for both. The U.S. Food and Drug Administration states that regenerative medicine therapies have not been approved for neurological, cardiovascular, and orthopedic conditions, among others. You can read this directly on the FDA’s page, Important Patient and Consumer Information About Regenerative Medicine Therapies.
That applies whether a clinic offers MSCs or MUSE cells. Neither choice is “approved” in the way a prescription drug is. So the practical questions are about quality, transparency, and honesty, not about which label sounds more advanced.
So Which One Is Better?
Here is the honest answer: there is no head-to-head human trial showing that MUSE cells outperform MSCs for any condition. Anyone who says otherwise is going beyond the evidence.
What we can say is more modest and still meaningful:
- MSCs have the longer track record and a larger body of research, with mixed results depending on the condition.
- MUSE cells have a different and intriguing profile in the lab, including homing behavior and broader cell potential, but less human evidence.
- The right choice depends on your health history, your goals, and what you have already tried.
On our Dezawa MUSE cells page, we explain that MUSE therapy is considered for people whose needs may go beyond what conventional MSC therapy provides. Whether that applies to you can only be decided in a real consultation.
Don’t Forget the Environment the Cells Enter
Whichever cell type is used, it still lands inside your body. In Chait’s clinical view, chronic inflammation, hormonal imbalance, and low cellular energy can make that environment less welcoming. That is why his care plans look at the whole picture instead of treating the injection as a standalone fix.
This reflects his clinical philosophy and general physiology. It has not been proven to improve outcomes with MUSE cells specifically. You can learn more about how this fits together on our stem cell therapy page.
Questions to Ask Before You Choose
Use these whether you are looking at MSCs, MUSE cells, or anything else at a stem cell clinic:
- Where do the cells come from, and how are they collected and tested?
- Is this part of a clinical trial, and how is the product regulated?
- What published human studies support its use for my specific condition?
- What are the realistic risks, and what happens if it does not work?
- Who performs each step, and what are their licenses?
- What is the full cost in writing?
A clinic that welcomes these questions is a good sign. One that dodges them is not.
Frequently Asked Questions
Are MUSE cells a type of mesenchymal stem cell?
MUSE cells are found within mesenchymal cell populations, so they are closely related to MSCs. However, researchers describe them as a distinct subgroup, identified by markers such as SSEA-3, with a broader range of abilities in laboratory studies.
Are MUSE cells better than regular stem cells?
There is no human trial proving that. MUSE cells show some different features in the lab, such as homing to injury and a wider range of cell types. MSCs, however, have a much longer clinical history. Your best option depends on your situation and should be discussed with a qualified provider.
Are MUSE cells embryonic stem cells?
No. MUSE cells are adult cells collected from tissues such as bone marrow, fat, and skin. They are not taken from embryos, and they do not require genetic reprogramming like iPSCs.
Why don’t more stem cell clinics offer MUSE cells?
MUSE cells are rare in tissue, need specialized isolation methods, and have a smaller body of human research than MSCs. That makes them harder to prepare and harder to standardize, so fewer providers offer them.
Is MUSE stem cell treatment more expensive than regular stem cell therapy?
Pricing varies by provider, product, and number of treatments, and neither option is typically covered by insurance. Ask for a written, itemized quote so you can compare options clearly.
Can I switch from MSC therapy to MUSE cells if MSCs did not help?
Some people explore that path, but there is no guarantee of a different result. A consultation can review what you tried, what you hoped for, and whether another approach is reasonable for you.
Talk With Our Team
Choosing between stem cell options should feel clear, not confusing. If you want an honest conversation about MUSE stem cells, MSCs, and what may or may not fit your situation, we are glad to help. Inquire About MUSE Cell Therapy to get started. Evan Chait works with patients across the United States.
MUSE cell therapy is an emerging area of regenerative medicine and is not FDA-approved as a standard treatment for any specific condition. Clinical research is ongoing. This content is for educational purposes only and is not medical advice. Evan Chait is a licensed Physical Therapist and Acupuncturist, not a medical doctor (MD). Always consult a qualified healthcare professional before pursuing any cellular therapy. Individual results may vary.